| Literature DB >> 35456238 |
Jouko Saramies1,2, Markku Koiranen2, Juha Auvinen2,3, Hannu Uusitalo4,5, Esko Hussi1, Sebastian Becker1, Sirkka Keinänen-Kiukaanniemi2,3,6, Jaakko Tuomilehto7,8, Kadri Suija2,9.
Abstract
There is a wide variation in the development and course of erectile dysfunction (ED) in men, which confirms the need for prospective studies. We conducted a cross-sectional analysis among the general male population at the baseline (n = 359) and in a follow-up survey (n = 218) 12 years later. The prospective 12-year study included 189 men. ED was assessed using the International Index of Erectile Function questionnaire. The mean age of the participants was 62.0 years at the baseline, while at the 12-year follow-up it was 71.6 years. The crude prevalence of ED was 61.6% at the baseline and 78.9% at the follow-up, and the prevalence tended to increase with age. All of the men aged 75 years or more had at least mild ED. The incidence of ED in every thousand person years was 53.5. A total of 54.5% of the men experienced ED progression, while 39.2% reported no changes in erectile function, and 6.3% experienced ED regression during the 12-year study. The likelihood of ED progression was higher in the older compared with younger age group (odds ratio, OR 5.2 (95% CI: 1.1-26.2)), and the likelihood of ED regression was lower among men with increased depression symptoms (OR 0.3 (95% CI: 0.1-0.6)) and among men with a decreased interest in their sexual life (OR 0.1 (95% CI: 0.0-0.6)). Lifestyle factors such as the consumption of alcohol and smoking were not significantly associated with ED.Entities:
Keywords: erectile dysfunction; follow-up studies; incidence; lifestyle; prevalence
Year: 2022 PMID: 35456238 PMCID: PMC9029758 DOI: 10.3390/jcm11082146
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1The flowchart for the study groupWe used the IIEF-5 to assess erectile function [15,16]. The IIEF-5 is a shorter version of the original IIEF questionnaire which comprises four questions from the sexual function domain of the original version and one question from the intercourse satisfaction domain. The IIEF was developed and then cross-culturally and linguistically validated in 1996–1997, while also being psychometrically tested. The IIEF-5 was originally designed to assess erectile function over the preceding four weeks. A period of six months was adopted for the standard assessment phase, following the recommendation of the National Institutes of Health [17]. Each question in the IIEF-5 is graded on a five-point scale, while four questions also include a score of zero, which indicates a totally lack of sexual activity. Based on the IIEF-5 scores, erectile function can be classified into five categories: severe ED (scoring 5–7 points), moderate ED (8–11 points), mild to moderate ED (12–16 points), mild ED (17–21 points), and no ED (22–25 points).
Distribution figures for specific socio-demographic and lifestyle variables, along with the frequency and prevalence (%) of erectile dysfunction (ED) in the categories for these variables in the baseline and twelve-year follow-up studies.
| Men Who Participated in the Baseline Study, | Men Who Participated in the Follow-Up Study, | Men Who Participated Both in the Baseline and Follow-Up Studies, | Incidence ** | |||||
|---|---|---|---|---|---|---|---|---|
| All | ED Prevalence | All | ED Prevalence | All | ED Prevalence at Baseline | ED Prevalence at Follow-up | ||
|
| % |
| % |
| ||||
|
|
|
|
|
| ||||
| 50–54 | 57 | 38.6 | 46 | 16 (34.8) | 33 (71.7) | 17 (56.7) 0.581 | ||
| 55–59 | 105 | 41.0 | 60 | 24 (40.0) | 36 (60.0) | 19 (52.8) 0.209 | ||
| 60–64 | 76 | 68.4 | 33 | 75.8 | 42 | 25 (59.5) | 37 (88.1) | 12 (70.6) 0.352 |
| 65–69 | 66 | 84.8 | 72 | 58.3 | 25 | 21 (84.0) | 25 (100) | 4 (100.0) 0.099 |
| 70–74 | 55 | 87.3 | 56 | 85.7 | 16 | 14 (87.5) | 16 (100) | 2 (100.0) 0.250 |
| 75–79 | 31 | 100 | ||||||
| 80–86 | 26 | 100 | ||||||
| Total | 359 | 61.6 | 218 | 78.9 | 189 | 100(52.9) | 147(77.8) | 54 (60.7) |
|
|
|
|
|
| ||||
| Higher | 19 | 42.1 | 23 | 56.5 | 19 | 8 (42.1) | 10 (52.6) | 3 (27.3) 0.024 |
| Vocational | 74 | 41.9 | 77 | 77.9 | 69 | 27 (39.1) | 52 (75.4) | 27 (64.3) 0.279 |
| Basic | 92 | 64.1 | 94 | 81.9 | 82 | 53 (64.6) | 67 (81.7) | 18 (62.1) 0.631 |
| Total | 185 | 53.0 | 194 | 77.3 | 170 | 88 (51.8) | 129 (75.9) | 48 (58.5) |
|
|
|
|
|
| ||||
| Upper | 55 | 60.0 | 60 | 75.0 | 49 | 28 (57.1) | 36 (73.5) | 11 (52.4) 0.491 |
| Upper middle | 18 | 50.0 | 20 | 65.0 | 18 | 9 (50.0) | 12(66.7) | 3 (33.3) 0.100 |
| Middle | 18 | 44.4 | 20 | 75.0 | 17 | 7 (41.2) | 12 (70.6) | 6 (60.0) 0.921 |
| Working | 56 | 53.6 | 56 | 80.4 | 52 | 27 (51.9) | 42 (80.8) | 17 (68.0) 0.233 |
| Other | 14 | 57 | 14 | 92.9 | 13 | 8 (61.5) | 12 (92.3) | 4 (80.0) 0.313 |
| Total | 161 | 54.) | 170 | 77.1 | 149 (100) | 79 (53.0) | 114 (76.5) | |
|
|
|
|
|
| ||||
| Married or cohabiting | 271 | 58.3 | 160 | 75.6 | 150 | 74 (49.3) | 112 (74.7) | 45 (59.2) 0.494 |
| Single, divorced, or widowed | 83 | 71.1 | 42 | 85.7 | 39 | 26 (66.7) | 35 (89.7) | 9 (69.2) 0.494 |
| Total | 354 | 61.3 | 202 | 77.7 | 189 | 100 (52.9) | 147 (77.8) | 54 (60.7) |
|
|
|
|
|
| ||||
| Never smoked | 142 | 64.1 | 84 | 81 | 84 | 50 (59.5) | 68 (81.0) | 19 (55.9) 0.467 |
| Stopped smoking | 129 | 65.1 | 92 | 78.3 | 64 | 35 (54.7) | 50 (78.1) | 19 (65.5) 0.516 |
| Current smoker | 76 | 50.0 | 19 | 78.9 | 35 | 12 (34.3) | 24 (68.6) | 13 (56.5) 0.636 |
| Total | 347 | 61.4 | 195 | 79.5 | 183 | 97 (53.0) | 142 (77.6) | 54 (60.7) |
|
|
|
|
|
| ||||
| No alcohol consumption | 43 | 72.1 | 33 | 84.8 | 23 (14.6) | 16 (69.6) | 19 (82.6) | 3 (42.9) 0.339 |
| <168 g | 210 | 57.1 | 116 | 75.0 | 120 (75.9) | 56 (46.7) | 92 (76.7) | 39 (60.9) 0.635 |
| ≥168 g | 32 | 62.5 | 14 | 71.4 | 15 (9.5) | 9 (60.0) | 10 (66.7) | 4 (66.7) 0.719 |
| Total | 285 | 60.0 | 163 | 76.7 | 158 (100) | 81 (51.3) | 121 (76.6) | 46 (59.7) |
|
|
|
|
|
| ||||
| <30 kg/m2 | 289 | 60.6 | 185 | 76.8 | 159 | 84 (52.8) | 119 (74.8) | 42 (56.0) 0.037 |
| ≥30 kg/m2 | 69 | 65.2 | 33 | 90.9 | 30 | 16 (53.3) | 28 (93.3) | 12 (85.7) 0.037 |
| Total | 358 | 61.5 | 218 | 78.9 | 189 | 100 (52.9) | 147 (77.8) | 54 (60.7) |
|
|
|
|
|
| ||||
| As before | 180 | 43.9 | 92 | 66.3 | 104 | 38 (36.5) | 75 (72.1) | 38 (57.6) 0.311 |
| Reduced | 171 | 78.4 | 108 | 87.0 | 82 | 59 (72.0) | 69 (84.1) | 16 (69.6) 0.311 |
| Not at all | 7 | 100 | 11 | 100 | 3 | 3 (100) | 3 (100) | 0 (0.0) |
| Total | 358 | 61.5 | 211 | 78.7 | 189 | 100 (52.9) | 147 (77.8) | 54 (60.7) |
|
|
|
|
|
| ||||
| <10 | 332 | 59.3 | 198 | 76.8 | 179 | 91 (50.8) | 138 (77.1) | 51 (60.7) 0.975 |
| ≥10 | 27 | 88.9 | 20 | 100 | 10 | 9 (90.0) | 9 (90.0) | 3 (60.0) 0.975 |
| Total | 359 | 61.6 | 218 | 78.9 | 189 | 100 (52.9) | 147 (77.8) | 54 (60.7) |
* p-values indicates whether the prevalence of ED is equal in each variable category(chi square test). ** The prevalence and incidence differ because the erectile function in seven men returned to normal. *** p-value indicates whether the observed incidence of a particular class is the same as the expected (total) incidence.
Figure 2The proportion of men who reported a normal erection ability, or mild, mild to moderate, moderate, or severe ED at the baseline (a) and at the twelve-year follow-up (b). The figures shown above the bars illustrate the number of men, and the vertical lines show the 95% confidence intervals for the prevalence of ED.
Logistic model with erectile dysfunction as the outcome, and statistically significant variables from Table 1 as risk factors. The unadjusted results, those with other variables’ adjusted odds ratios (OR), and their 95 percent confidence intervals (95% CI) are presented.
| Variable | All Men | Men Participated to Both Baseline and Follow-Up | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline ( | Follow-Up ( | Baseline ( | Follow-Up ( | |||||
| Category | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) |
|
| ||||||||
| 50–54 | ref | ref | ref | ref | ||||
| 55–59 | 1.1 (0.6,2.1) | 0.9 (0.4,1.9) | 1.3 (0.6,2.8) | 1.0 (0.4,2.5) | ||||
| 60–64 | 3.4 (1.7,7.1) | 2.5 (1.1,5.6) | ref | ref | 2.8 (1.2,6.5) | 2.6 (1.0,7.1) | ref | ref |
| 65–69 | 8.9 (3.8,21.0) | 6.1 (2.4,15.8) | 0.4 (0.2,1.1) | 0.4 (0.1,1.2) | 9.8 (2.9,33.7) | 10 (2.6,40.1) | 0.4 (0.2,1.2) | 0.4 (0.1,1.2) |
| 70 and over | 11.0 (4.2,28.4) | 6.3 (2.2,18.1) | 4.2 (1.4,12.3) | 3.8 (1.2,12.1) | 13.0 (2.6,65.1) | 7.9 (1.4,43.6) | 3.7 (1.2,10.8) | 3.5 (1.1,11.3) |
|
| ||||||||
| Higher or vocational | ref | ref | ref | ref | ref | ref | ref | ref |
| Basic | 2.5 (1.4,4.5) | 2.7 (1.4,5.4) | 1.7 (0.8,3.3) | 1.5 (0.7,3.6) | 2.8 (1.5,5.2) | 3.0 (1.4,6.3) | 1.9 (0.9,3.9) | 1.7 (0.7,4.0) |
|
| ||||||||
| Married or cohabiting | ref | ref | ref | ref | ref | ref | ref | ref |
| Single, divorced, or widowed | 1.8 (1.0,3.0) | 2.1 (1.1,3.9) | 1.9 (0.8,4.9) | 3.0 (0.9,9.7) | 2.1 (1.0,4.3) | 3.0 (1.2,7.5) | 3.0 (1.0,8.9) | 4.1 (1.1,14.4) |
| Body mass index | ||||||||
| <30 kg/m2 | ref | ref | ref | ref | ref | ref | ref | ref |
| ≥30 kg/m2 | 1.5 (0.8,2.8) | 1.1 (0.5,2.4) | 3.0 (0.9,10.4) | 3.6 (0.7,18.6) | 0.7 (0.3,1.8) | 0.7 (0.2,2.4) | 4.1 (0.9,18.1) | 3.7 (0.7,19.5) |
| Interest in sexual life | ||||||||
| As before | ref | ref | ref | ref | ref | ref | ref | ref |
| Reduced or not at all | 4.9 (3.1,7.8) | 3.3 (1.9,5.7) | 3.8 (1.9,7.7) | 2.8 (1.2,6.8) | 4.7 (2.5,8.7) | 4.0 (1.9,8.4) | 4.1 (1.9,8.6) | 3.3 (1.3,8.1) |
| Beck’s BDI-I score | ||||||||
| <10 | ref | ref | ref | ref | ref | ref | ref | ref |
| ≥10 | 3.7 (1.8,7.7) | 2.4 (1.1,5.6) | 5.4 (1.3,23.5) | 2.5 (0.5,12.8) | 3.9 (1.4,11.1) | 3.4 (1.0,11.3) | 5.1 (1.2,22.4) | 2.3 (0.4,12.3) |
Prevalence and changes in erectile dysfunction from the baseline to the 12-year follow-up.
| ED at the Baseline | ||||||
|---|---|---|---|---|---|---|
| No ED | Mild | Mild to Moderate | Moderate | Severe | Total | |
| ED at 12-Year | ||||||
| No ED | 35 (39.3) | 7 (11.9) | 42 (22.2) | |||
| Mild | 36 (40.4) | 23 (39.0) | 3 (12.5) | 62 (32.8) | ||
| Mild to moderate | 10 (11.2) | 14 (23.7) | 3 (12.5) | 1 (20.0) | 28 (14.8) | |
| Moderate | 1 (1.1) | 7 (11.9) | 5 (20.8) | 2 (40.0) | 1 (8.3) | 16 (8.5) |
| Severe | 7 (7.9) | 8 (13.6) | 13 (54.2) | 2 (40.0) | 11 (91.7) | 41 (21.7) |
| Total | 89 (100) | 59 (100) | 24 (100) | 5 (100) | 12 (100) | 189 (100) |
Figure 3Changes in erectile function flow and changes according to the IIEF-5 during the 12-year follow-up period.
Factors which were important in terms of the progression and regression of ED.
| Erectile Function Remained Same or Improved | Erectile Function Decreased | Erectile Dysfunction Persistence | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
| % | OR (95% CI) |
| % | OR (95% CI) |
| % | OR (95% CI) | |
|
|
|
|
| ||||||
| 50–54 | 46 | 28.3 | ref | 45 | 53.3 | ref | 46 | 34.8 | ref |
| 55–59 | 60 | 41.7 | 1.8 (0.8,4.1) | 59 | 44.1 | 0.7 (0.3,1.5) | 60 | 28.3 | 0.7 (0.3,1.7) |
| 60–64 | 42 | 19 | 0.6 (0.2,1.6) | 37 | 64.9 | 1.6 (0.7,3.9) | 42 | 59.5 | 2.8 (1.2,6.5) |
| 65–69 | 25 | 4 | 0.1 (0.0,0.9) | 22 | 77.3 | 3.0 (0.9,9.5) | 25 | 84 | 9.8 (2.9,33.7) |
| 70–75 | 16 | 0 | n.a. | 14 | 85.7 | 5.2 (1.1,26.2) | 16 | 87.5 | 13.1 (2.6,65.1) |
|
|
|
|
| ||||||
| Higher or vocational | 88 | 33 | ref | 81 | 55.6 | ref | 88 | 36.4 | ref |
| Basic | 82 | 20.7 | 0.5 (0.3,1.1) | 80 | 60 | 1.2 (0.6,2.2) | 82 | 59.8 | 2.6 (1.4,4.8) |
|
|
|
|
| ||||||
| Upper | 49 | 30.6 | ref | 46 | 54.3 | ref | 49 | 51 | ref |
| Upper middle | 18 | 38.9 | 1.4 (0.5,4.4) | 17 | 52.9 | 0.9 (0.3,2.9) | 18 | 50 | 1.0 (0.3,2.8) |
| Middle | 17 | 29.4 | 0.9 (0.3,3.2) | 16 | 50 | 0.8 (0.3,2.6) | 17 | 35.3 | 0.5 (0.2,1.6) |
| Working | 52 | 21.2 | 0.6 (0.2,1.5) | 50 | 56 | 1.1 (0.5,2.4) | 52 | 48.1 | 0.9 (0.4,1.9) |
| Other | 13 | 7.7 | 0.2 (0.0,1.6) | 10 | 90 | 7.6 (0.9,64.6) | 13 | 61.5 | 1.5 (0.4,5.4) |
|
|
|
|
| ||||||
| Married or cohabiting | 150 | 28 | ref | 142 | 59.9 | ref | 150 | 44.7 | ref |
| Single, divorced, or widowed | 39 | 12.8 | 0.4 (0.1,1.0) | 35 | 51.4 | 0.7 (0.3,1.5) | 39 | 66.7 | 2.5 (1.2,5.2) |
|
|
|
|
| ||||||
| Nonsmoker at baseline–nonsmoker at follow-up | 133 | 23.3 | ref | 125 | 59.2 | ref | 133 | 51.9 | ref |
| Smoker at baseline–nonsmoker at follow-up | 13 | 38.5 | 2.1 (0.6,6.7) | 11 | 45.5 | 0.6 (0.2,2.0) | 13 | 38.5 | 0.6 (0.2,1.9) |
| Smoker at baseline–smoker at follow-up | 15 | 26.7 | 1.2 (0.4,4.0) | 15 | 60 | 1.0 (0.3,3.1) | 15 | 26.7 | 0.3 (0.1,1.1) |
|
|
|
|
| ||||||
| No alcohol at all | 16 | 37.5 | ref | 13 | 53.8 | ref | 16 | 75 | ref |
| Same or decreased | 75 | 26.7 | 0.6 (0.2,1.9) | 72 | 61.1 | 1.3 (0.4,4.4) | 75 | 40 | 0.2 (0.1,0.8) |
| Increased | 51 | 25.5 | 0.6 (0.2,1.9) | 47 | 55.3 | 1.1 (0.3,3.6) | 51 | 45.1 | 0.3 (0.1,1.0) |
|
|
|
|
| ||||||
| BMI same or decreased | 105 | 27.6 | ref | 96 | 57.3 | ref | 105 | 52.4 | ref |
| MI increased | 84 | 21.4 | 0.7 (0.4,1.4) | 81 | 59.3 | 1.1 (0.6,2.0) | 84 | 45.2 | 0.8 (0.4,1.3) |
|
|
|
|
| ||||||
| Increased | 21 | 28.6 | ref | 20 | 65 | ref | 21 | 61.9 | ref |
| No change | 105 | 35.2 | 1.4 (0.5,3.8) | 97 | 46.4 | 0.5 (0.2,1.3) | 105 | 40 | 0.4 (0.2,1.1) |
| Decreased | 57 | 5.3 | 0.1 (0.0,0.6) | 55 | 76.4 | 1.7 (0.6,5.3) | 57 | 59.6 | 0.9 (0.3,2.5) |
|
|
|
|
| ||||||
| Same or decreased | 97 | 35.1 | ref | 93 | 52.7 | ref | 97 | 41.2 | ref |
| Increased | 92 | 14.1 | 0.3 (0.1,0.6) | 84 | 64.3 | 1.6 (0.9,3.0) | 92 | 57.6 | 1.9 (1.1,3.5) |